Target (CBDY) Equity Ratio (2013 - 2026)

Target (CBDY) reported Equity Ratio of 1.41 for Q1 2026, down 41.72% year-over-year from 2.41 in Q1 2025, and down 7.72% quarter-over-quarter from 1.31 in Q4 2025.

Target (CBDY) Equity Ratio (2013 - 2026) Analysis & Trends

Target (CBDY) has 14 years of Equity Ratio data on file, last reported at 1.41 in Q1 2026.

  • Equity Ratio for Q1 2026 came in at 1.41, down 41.72% year-over-year; the trailing twelve-month figure through Mar 2026 was 1.41 (down 41.72% YoY), and the FY2025 annual result was 1.31, down 51.92% from the prior year.
  • Equity Ratio retreated to 1.41 in Q1 2026 per CBDY's latest filing, from 1.31 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.2 in Q1 2022 and troughed at 1.41 in Q1 2026.
  • A 5-year average of 0.85 and a median of 0.89 in 2024 frame the typical range for Equity Ratio.
  • The sharpest annual moves came in 2022 and 2023: Equity Ratio surged 46.28% in 2022, then plunged 366.38% in 2023.
  • A 5-year view of Equity Ratio shows it stood at 0.26 in 2022, then plunged by 200.52% to 0.79 in 2023, then decreased by 8.95% to 0.86 in 2024, then plunged by 51.92% to 1.31 in 2025, then slipped by 7.72% to 1.41 in 2026.
  • Business Quant data shows CBDY's Equity Ratio at 1.41 in Q1 2026, 1.31 in Q4 2025, and 1.2 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 0.21
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 0.21
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 0.88
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 0.73
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 0.69
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 0.49
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 0.41
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 0.52
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 0.20
10 Target - - 191,787.00 -1.41

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.41
Dec 31, 2025 -1.31
Sep 30, 2025 -1.20
Jun 30, 2025 -1.07
Mar 31, 2025 -0.99
Dec 31, 2024 -0.86
Sep 30, 2024 -0.92
Jun 30, 2024 -0.81
Mar 31, 2024 -1.00
Dec 31, 2023 -0.79
Sep 30, 2023 -0.82
Jun 30, 2023 -0.73
Mar 31, 2023 -0.95
Sep 30, 2022 -0.26
Jun 30, 2022 -0.22
Mar 31, 2022 -0.20
Sep 30, 2021 -0.16
Jun 30, 2021 -0.31
Mar 31, 2021 -0.38
Dec 31, 2020 -0.27